Staff turnover in EUR1,930,4791,517,2682,205,3132,311,3392,722,226
Staff turnover in EUR1,930,4791,517,2682,205,3132,311,3392,722,226
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)140.97147.05136.0916,166.80153.20
Dividend per share-----
Basic earnings per share0.03-0.020.050.070.10
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover17,741.924,959.330,607.529,508.633,034.8
Operating income (EBIT)35.6-56.327.557.3140.6
Earnings before taxes502.6-250.9617.11,032.11,754.0
Annual net profit/ loss398.5-322.1610.0964.61,546.5
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets16,841.416,748.417,036.514,632.113,171.0
Total fixed assets4,197.96,959.06,664.16,706.49,551.2
Total assets21,039.323,707.423,700.621,338.522,722.2
Liabilities
Total short-term liabilities4,033.55,953.66,211.45,442.05,087.8
Total long-term liabilities67.3379.8185.9175.7132.1
Total provisions0.00.00.00.00.0
Equity capital16,938.517,374.017,303.315,720.817,502.3
Total liabilities21,039.323,707.423,700.621,338.522,722.2
Management:
Difan Shen
Hua Zhang
Shunyan Zhu
Yan Deng
Yanwu Tu
Board:
Rong Shao
Haipeng Xu
Jiao Jiao Huang
Meng Yue Sheng
Yi Fei Huang
Yi Hong Wu
Shareholding in %:
Address: 26/F, Tower One, Times Square, 1 Matheson Street, Hong Kong
T: +852-2583-9333
F: +852-2215-5200
I: http://www.alihealth.cn
E: